Biochemistry, Genetics and Molecular Biology
CRISPR
96%
CRISPR/Cas9
86%
Oncogene
65%
Carcinogenesis
62%
Deficiency
57%
Transgenics
46%
Tumor Suppressor Protein
46%
JUNB
40%
Transcription Factors
39%
Mouse Model
39%
Cas9
35%
Allele
35%
Gene Mutation
34%
Hematopoietic Cell
34%
Porcine Model
34%
Transcription Factor Sox9
34%
Hepatocyte
30%
Promoter Region
28%
Mouse Mutant
28%
Cancer Cell
28%
Immunosurveillance
25%
Lentivirus
25%
Genome Editing
25%
Cell Proliferation
25%
Minipig
24%
Transgene
23%
T Cell
23%
Epigenetics
21%
Cre Recombinase
21%
Embryogenesis
20%
Adeno Associated Virus
20%
Tumor Suppressor Gene
19%
Transcription Factor Fra 1
19%
Tumor Progression
19%
Ribonucleoprotein
19%
Oncogene C Myc
19%
Cancer Model
17%
Guide RNA
17%
Chimeric Antigen Receptor
17%
Activator Protein 1
17%
Transcription Factor Fra 2
17%
Catenin
17%
Epidermal Growth Factor Receptor
17%
Xenobiotic Metabolism
17%
FOXP1
17%
Membrane Curvature
17%
Synapsin I
17%
SOX9
17%
FERM Domain
17%
Gene Cluster
17%
Medicine and Dentistry
Prostate Cancer
100%
Clustered Regularly Interspaced Short Palindromic Repeat
82%
Prostate Epithelium
48%
Hepatocyte
43%
Base
40%
Cas9
32%
Tumor
30%
Interferon
29%
Cancer Growth
24%
Xenograft
23%
Neoplasm
23%
Carcinogenesis
22%
Herpes Simplex Virus 2
21%
Cell Death
21%
Lentivirus
20%
Gene Mutation
20%
Metastatic Carcinoma
19%
Tumor Microenvironment
19%
Prostate Tumor
18%
Transcription Factor Sox9
17%
Urogenital Sinus
17%
Chimeric Antigen Receptor T-Cell
17%
Glioblastoma
17%
Synapsin I
17%
Hepatitis B Virus
17%
Hepatitis B
17%
Caspase 2
17%
Androgen
17%
Multigene Family
17%
Neural Crest Cell
17%
Adeno Associated Virus Vector
17%
Herpes Genitalis
17%
Embryo Development
17%
Cell Differentiation
17%
Sertoli Cell
17%
Oncogene C Fos
17%
Liver Carcinogenesis
17%
Tumor Immunity
17%
Chronic Granulomatous Disease
17%
Arabinoside
17%
Chondrocyte
17%
Radioactive Tracer
17%
Glucose Metabolism
17%
Hypoxia
17%
Complementary DNA
17%
Tumor Model
17%
Hematopoietic Cell
17%
Regulatory Sequence
17%
Ribonucleoprotein
17%
Nanoparticle
17%
Keyphrases
Prostate Cancer
41%
Hematopoietic Stem Cells
34%
Cell Proliferation
33%
Oncogene
28%
Hepatocellular Carcinoma
28%
Stimulator of Interferon Genes (STING)
24%
Cas9 Protein
24%
Targeted Integration
21%
C-Jun
20%
Fos-related Antigen 2
20%
Autophagy
19%
CGAS-STING
19%
Transcription Factor
19%
Hepatocytes
18%
Enveloped RNA Viruses
17%
Driver mutations
17%
Epithelial Plasticity
17%
Non-viral
17%
Porcine Model
17%
NF-B
17%
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
17%
Cancer Development
17%
Stimulator of Interferon Genes Agonist
17%
2′3′-cGAMP
17%
Microenvironment
17%
Allogeneic
17%
Intestinal Cancer
17%
Chronic Granulomatous Disease
17%
Overexpression
17%
Interferon Regulatory Factor 3 (IRF3)
17%
GATA2 Deficiency
17%
ER Exit
17%
Gene Correction
17%
CDCA2
17%
Dual Tracer
17%
Tumor Microenvironment
17%
Endolysosomal
17%
Therapeutic Target
17%
Genetically Engineered Mouse Models
17%
Hepatitis B Virus
17%
Targeted Gene Delivery
17%
Access Link
17%
Collagen I
17%
Hypoxia
17%
FERM Domain
17%
Metastatic Cancer
17%
Prostate
17%
DNA Sensing
17%
Liver Cancer
17%
Hepatitis B Virus Infection
17%
